semaglutide and cancer risk Can obesity meds also reduce risk? A retrospective study of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked Ozempic and Wegovy may help

"Expanding Medicaid coverage of these drugs could increase access for the almost 40% of adults and 26% of children with obesity in Medicaid," wrote the research team led by senior investigator Clea Bell, a research assistant in state health reform for KFF

Neuroscience 277:747754 Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis

We provide a completely personalised experience

Our licensed and certified internal medicine doctors can help you determine if weight loss injections are the right treatment plan for you

Adaptive thermogenesis reduces the calories you burn at rest beyond what would be expected from decreased body mass alone